Brief: Parataxis, Bridge Biotherapeutics Ink Deal to List Bitcoin Treasury Firm on Korea's KOSDAQ
20/06/2025 11:48
June 20 (Reuters) - Bridge Biotherapeutics Inc 288330.KQ: PARATAXIS HOLDINGS LLC ANNOUNCES DEFINITIVE AGREEMENT WITH BRIDGE BIOTHERAPEUTICS, INC. (KOSDAQ: 288330), TO BRING INSTITUTIONALLY-BACKED, BITCOIN TREASURY COMPANY TO THE SOUTH KOREAN PUBLIC MARKETS: PARATAXIS HOLDINGS: TO INVEST KRW 25 BILLION IN BRIDGE BIOTHERAPEUTICS PARATAXIS HOLDINGS- COMPANY TO CHANGE NAME TO PARATAXIS KOREA POST-DEAL PARATAXIS HOLDINGS - UNDER DEAL, ANDREW KIM TO ASSUME CEO ROLE AND JOIN BOARD Source text: ID:nPreF8M1Va Further company coverage: 288330.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Parataxis Korea
See all newsBrief: Parataxis, Bridge Biotherapeutics Ink Deal to List Bitcoin Treasury Firm on Korea's KOSDAQ
Brief: Bridge Biotherapeutics Announces Completion Of Enrollment In The Phase 2A Clinical Study Of BBT-877 For The Treatment Of Idiopathic Pulmonary Fibrosis
Brief: Bridge Biotherapeutics Launches A Research Collaboration With Emory University School Of Medicine
Brief: Bridge Biotherapeutics Announces A Research Collaboration With The University Of Colorado School Of Medicine
Brief: Bridge Biotherapeutics To Conduct Capital Increase Of 2 Billion Won For Operational Funds